Castlemen disease is a lymphoproliferative disorder of unknown etiology, was first described as a distinct entity by Castlemen et al in 1956. The disease has two clinical (localized and multicentric) and two histopathological forms (hyalinevascular and plasma cell). This disease is usually, clinically misunderstood as lymphoma, carcinoma metastatic-lymph nodes, or tuberculosis. We, therefore, represent clinicopathological findings of 11 cases of Castlemen disease seen in Hanoi K Hospital. Results: Most patients are women (F:M=4.5:1), age ranges from 15-52 year old with average is 33. The affected nodes are often enlarged (3cm in 63.6%). Localized form is prominent with proportion of 63.6%. The treatment is still problematic, but complete surgical excision is the treatment of choice for localized form and is generally curative.
Lymphoproliferative Disorders ; diagnosis

No abstract available.
DNA* ; Lymphoproliferative Disorders*

No abstract available.
DNA* ; Lymphoproliferative Disorders*

No abstract available.
Lymphoproliferative Disorders ; T-Lymphocytes

Diffuse plane xanthoma characteristically presents with asymptomatic, yellow-orange plaques that usually involve periorbital areas, neck, upper trunk and flexural folds. Al-though most cases of diffuse plane xanthoma are associated with multiple myeloma, several cases have been described with different lymphoproliferative disorders and other miscellaneous diseases. We report herein two cases of diffuse plane xanthoma which are not associated with underlying disease.
Lymphoproliferative Disorders ; Multiple Myeloma ; Neck ; Xanthomatosis*

Lymphoproliferative disorders of the lung consist of a spectrum of several entities from malignant lymphoma to variable non-lymphomatous lymphoproliferative disorders. While an entity may be histologically benign and can be cured without treatment or by surgical removal, malignancy may evolve, and aggressive treatment may thus be required. Radiographic and pathologic findings of an entity may overlap, but differential diagnosis of lymphoproliferative disorders of the lung is nonetheless important. In this paper we illustrate a variety of lymphoproliferative diseases of the lung that have been pathologically proven during the last ten years, and discuss their radiographic and pathologic characteristics.
Diagnosis, Differential ; Lung* ; Lymphoma ; Lymphoproliferative Disorders*

Castleman's disease or angiofollicular lymph node hyperplasia is a rare lymphoproliferative disorder. Complete surgical resection was recommended in unicentric Castleman's disease. Radiotherapy was considered alternative therapeutic option. However, there have been consistent favorable responses to radiotherapy. We also experienced two cases of uncentric Castleman's disease salvaged successfully with radiotherapy. This paper described these cases and reviewed the literature about Castleman's disease treated with radiotherapy. Reviewed cases showed that radiotherapy is a successful treatment option in unicentric Castleman's disease. Furthermore, our report confirms the radiotherapy role in uncentric Castleman's disease.
Giant Lymph Node Hyperplasia ; Lymphoproliferative Disorders

Humans ; Lymphoproliferative Disorders ; classification ; World Health Organization

No abstract available.
Herpesvirus 4, Human ; Lymphoproliferative Disorders ; Primary Myelofibrosis

Gastrointestinal Tract ; Humans ; Lymphoproliferative Disorders ; T-Lymphocytes